Novo Nordisk A S NVO
NYSE NVO
$38.89 -0.56 (-1.42%)
At close: Nov 19, 2026 · 4:00 PM EST

Novo Nordisk A S (NVO) Research & Development (2012 - 2016)

Updated

Novo Nordisk A S (NVO) posted Research & Development of $651 million for the quarter ended Dec 31, 2016.

Analysis

Novo Nordisk A S (NVO) Research & Development (2012 - 2016) Analysis & Trends

For the trailing twelve months through Dec 31, 2016, Research & Development at Novo Nordisk A S was $33.85 billion; for the year ended Dec 31, 2013, it was $11.73 billion, up 7.7% from the prior year.

  • Annual Research & Development has increased for four consecutive years, with a four-year compound annual growth rate of 10.5% (years ended Dec 2009 to Dec 2013).
  • In prior years, Novo Nordisk A S's Research & Development was $10.9 billion in the year ended Dec 31, 2012 (+13.2%), $9.63 billion in the year ended Dec 31, 2011 (+0.3%), $9.6 billion in the year ended Dec 31, 2010 (+22.1%) and $7.86 billion in the year ended Dec 31, 2009.
  • The figure for the quarter ended Dec 31, 2016 stands as the highest quarterly Research & Development since the quarter ended Dec 31, 2014.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 651.00 Mn
Dec 31, 2014 13.76 Bn
Dec 31, 2012 10.90 Bn
API Access

Novo Nordisk A S Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=NVO&period=max&api_key=YOUR_API_KEY